Alterations in the Plasma Lipidome and Links to Clinical Assessments During Breast Cancer Treatment
Year: 2026
Type: article
Abstract: Objectives: Anthracycline-based chemotherapies (anth-bc) reduce left ventricular ejection fraction (LVEF) and exercise capacity placing breast cancer (BC) survivors at an increased risk of heart failure. Application of untargeted lipidomics can identify plasma lipids altered by anth-bc to serve as nutritional targets that attenuate declines in clinical assessments.
Institutions: Virginia Commonwealth University, Emory University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,000
Funder: National Institutes of Health
OpenAlex ID: W7170959034